Skip to main content
. 2017 Jul 30;10(3):118–125. doi: 10.1159/000447164

Fig. 3.

Fig. 3

Diagram showing percentages of upgraded and not upgraded tumors in low-risk PCa patients classified by P+ (< 0.20 vs. ≤ 0.20) and PSA (> 5 vs. ≤ 5 ug/L) and related to tumor extension of the prostatectomy specimen (V+, percentage of the tumor mass related to the volume of the gland).